Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain by Serafini, Barbara et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
JEM © The Rockefeller University Press  $30.00
Vol. 204, No. 12,  November 26, 2007  2899-2912  www.jem.org/cgi/doi/
2899
10.1084/jem.20071030
        The etiology of multiple sclerosis (MS), a puta-
tive autoimmune disease aff  ecting the central 
nervous system (CNS) and causing severe neu-
rological disability, remains unknown but is likely 
to involve both heritable and nonheritable fac-
tors (  1, 2  ). Among the latter, infectious agents 
are the most plausible candidates. Over the past 
50 yr, several pathogens have been proposed as 
the potential causal factor in MS, but for most of 
them inconsistent results have been obtained (  3  ). 
To date, EBV stands out as the infectious agent 
for which there is the most compelling evidence 
for an association with MS (  3  –  6  ), as well as with 
other autoimmune diseases (  7  –  9  ). 
  EBV is a B-lymphotropic human DNA her-
pesvirus that establishes asymptomatic latent infec-
tion in most individuals and can cause infectious 
mononucleosis in adolescents and young adults. 
Latently infected B cells can express three dif-
ferent programs of viral gene usage depending 
on the diff  erentiation state of the infected B 
cell (  10, 11  ). Analysis performed in the tonsils 
of healthy EBV carriers have shown that naive 
B cells, which are thought to be newly infected 
cells, express all nine known latency proteins 
(Epstein-Barr nuclear antigen [EBNA]1, 2, 3a, 
3b, 3c, -LP, and latency membrane protein 
[LMP]1, 2a, and 2b; growth program), whereas 
germinal center and memory B cells express a 
more limited set of latency proteins (EBNA1, 
LMP1, and LMP2a; default program) (  12  ). In the 
blood, the virus persists in rare memory B cells 
expressing no viral proteins, except perhaps 
EBNA1 and LMP2a (latency program) (  12  ). 
Occasionally, viral replication occurs in tonsillar 
plasma cells, resulting in expression of lytic genes 
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  Epstein-Barr virus (EBV), a ubiquitous B-lymphotropic herpesvirus, has been associated with 
multiple sclerosis (MS), an infl  ammatory disease of the central nervous system (CNS), but 
direct proof of its involvement in the disease is still missing. To test the idea that MS might 
result from perturbed EBV infection in the CNS, we investigated expression of EBV markers 
in postmortem brain tissue from MS cases with different clinical courses. Contrary to 
previous studies, we found evidence of EBV infection in a substantial proportion of brain-
infi  ltrating B cells and plasma cells in nearly 100% of the MS cases examined (21 of 22), 
but not in other infl  ammatory neurological diseases. Ectopic B cell follicles forming in the 
cerebral meninges of some cases with secondary progressive MS were identifi  ed as major 
sites of EBV persistence. Expression of viral latent proteins was regularly observed in MS 
brains, whereas viral reactivation appeared restricted to ectopic B cell follicles and acute 
lesions. Activation of CD8  +   T cells with signs of cytotoxicity toward plasma cells was also 
noted at sites of major accumulations of EBV-infected cells. Whether homing of EBV-
infected B cells to the CNS is a primary event in MS development or the consequence of a 
still unknown disease-related process, we interpret these fi  ndings as evidence that EBV 
persistence and reactivation in the CNS play an important role in MS immunopathology. 2900 EBV IN MULTIPLE SCLEROSIS | Serafi  ni et al.
ence of prominent B cell/plasma cell infi  ltration in white 
matter lesions and the formation of ectopic B cell follicles 
in the meninges (  46, 47  ). We then extended the search for 
EBV markers to 12 relapsing-remitting and progressive MS 
cases with less brain infl  ammation and to 2 cases with acute 
MS. Here, we show that intracerebral accumulation of EBV-
infected B cells and plasma cells is a regular feature of MS 
and identify ectopic B cell follicles as main sites of viral 
persistence. We also provide evidence for a relationship 
between acute infl  ammation and EBV reactivation in the 
MS brain and for CD8  +   T cell activation and cytotoxicity 
toward virally infected B cells/plasma cells. These fi  ndings 
support a role for EBV in MS pathogenesis through persis-
tent infection of brain-infi  ltrating B cells and the induction 
of immunopathology. 
    RESULTS   
  Germinal center  –  like features of ectopic B cell follicles 
and B cell proliferation in acute lesions in the MS brain: 
fi  rst hint of a dysregulated EBV infection 
  Recently, we identified a subset of early-onset MS cases 
who died in the secondary progressive phase of the disease 
(which follows a relapsing-remitting course in 80  –  85% of 
the MS patient population) and were characterized by highly 
infi  ltrated white matter lesions, presence of lymphocytic ag-
gregates resembling ectopic B cell follicles in the cerebral 
meninges, and extensive demyelination and axon loss in the 
adjacent cerebral cortex (  Fig. 1 A  ) (  47  ).   Intrameningeal B 
cell follicles display features of germinal centers, as they are 
composed of CD20  +   B cells clustered around a network 
of stromal/follicular dendritic cells that express the B cell  – 
attracting chemokine CXCL13 (  Fig. 1 B  ) and are the sites 
where B cell proliferation (  Fig. 1 C  ) and diff  erentiation into 
Ig-producing plasma cells occurs (  Fig. 1 D  ). Here, we provide 
additional evidence that MS ectopic follicles are functional 
structures involved in B cell maturation, as they contain 
numerous cells expressing activation-induced cytidine deaminase 
(AID), the enzyme responsible for somatic hypermutation 
and Ig class-switch recombination in germinal center B cells 
(  Fig. 1 E  ), and cells expressing activated caspase-3 (  Fig. 1 F  ), 
which mediates apoptosis of B cells with low affi   nity vari-
ants of the B cell receptor. Intrameningeal B cell follicles 
are also enriched in cells expressing the antiapoptotic mol-
ecule bcl-2, which promotes survival of positively selected 
germinal center B cells (  Fig. 1 G  ). In the same set of highly 
infi  ltrated MS brains, substantial numbers of bcl-2  +   cells 
were present in some of the intraparenchymal B cell  –  en-
riched perivascular cuff  s (  Fig. 1 G  , inset) and B cell prolifer-
ation was noted in acute lesions (  Fig. 1 H  ). Because EBV can 
deliver proliferative, antiapoptotic and activation signals to 
B cells through expression of latency proteins (  11  ), and be-
cause the lymphoid tissue is the main site of EBV persistence 
and replication (  10  ), we postulated that EBV could promote 
intracerebral expansion and maturation of B cells and use 
ectopic lymphoid tissue to establish persistent infection in 
the MS brain. 
and shedding of low numbers of viral particles in the saliva (  13  ). 
Host immune surveillance is essential both in limiting pro-
ductive infection and in controlling latent infection. Infectious 
virus is destroyed by neutralizing antibodies, and all infected 
states, both lytic and latent, are the targets of cytotoxic CD8  +   
T cells, with the exception of latently infected, circulating 
memory B cells (  14  ). 
  During the last two decades, sero-epidemiological studies 
have consistently shown that the EBV seropositivity rate in MS 
patients is higher than in controls (99% vs. 90  –  95% [  4, 5, 15  –  17  ]; 
83  –  99% in children with MS compared with 42  –  72% in 
age-matched controls [  18, 19  ]). This high seroprevalence 
rate does not apply to other viruses (  4, 17, 19  ), suggesting that 
EBV infection is a prerequisite for the development of MS. 
Furthermore, an increased risk of developing MS has been associ-
ated with infectious mononucleosis (  20  –  22  ) and higher serum 
levels of anti-EBV antibodies (  4, 16, 19, 23  –  25  ). Elevations 
in anti-EBV antibody titers, particularly IgG antibodies to 
EBNA complex and EBNA-1, have been detected up to 20 yr 
before the onset of MS symptoms (  24, 25  ), suggesting a role 
for remote exposure to EBV in MS development. An increased 
humoral immune response to EBV was also demonstrated in 
the cerebrospinal fl  uid (CSF) of patients with MS (  26  ), and 
oligoclonal IgG binding to EBNA1 (  27, 28  ) and another 
less well characterized EBV antigen (BRRF2) (  28  ) were 
found in the CSF of some MS patients. Recently, increased 
CD4  +   and CD8  +   T cell responses specific for EBV have 
been detected in the CSF (  29, 30  ) and blood (  28, 31, 32  ) of 
MS patients, consistent with abnormal immune activation 
toward the virus. 
  Several hypotheses have been addressed to explain the 
breaking of immune tolerance by EBV, including molecular 
mimicry between viral and myelin components (  33  –  35  ), 
EBV-induced expansion of autoreactive B cells (  36  ), and in-
duction of heat-shock proteins (  37  ) and superantigens (  38  ), 
but evidence that these mechanisms are relevant to MS is not 
available yet. Because of its ability to establish a latent infec-
tion in B cells, to promote their proliferation and activation, 
and to reactivate periodically providing a constant antigenic 
challenge to the immune system (  10, 11  ), EBV is well suited 
to be a trigger of chronic infl  ammatory states. However, in 
the absence of any data demonstrating the presence of EBV 
in the MS brain (  39, 40  ) and a substantial increase of viral DNA 
load in the blood of MS patients compared with asymp  tomatic 
carriers (  6, 32, 41  ), the link between EBV-related immune 
alterations and MS remains unclear. 
  Because intrathecal synthesis of Ig (predominantly oligo-
clonal IgG) is common to most MS patients (  42  ), and clon-
ally expanded memory B cells have been detected in MS 
brain lesions and CSF (  43  –  45  ), we asked whether such an 
abnormal and compartmentalized humoral immune response 
could result from a perturbed EBV infection in the CNS. 
To approach this question, we investigated the expression 
of markers of EBV latent and lytic infection in postmortem 
brain specimens from eight cases with secondary progres-
sive MS that we had previously characterized for the pres-JEM VOL. 204, November 26, 2007 
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B cells were positive for EBER transcripts (  Fig. 2, C and D,   
and Table S1). The highest percentage of B cells expressing 
EBERs was detected inside and around ectopic B cell follicles 
(  Fig. 2 C  ), suggesting that these structures may originate from 
the expansion of EBV-infected B cells. Such an enrichment of 
EBV-infected cells in ectopic follicles is in contrast with what 
has been observed in the tonsils of healthy EBV carriers and 
subjects with infectious mononucleosis in which most infected 
B cells are found outside B cell follicles (  11  ). A substantial pro-
portion of brain-infi  ltrating plasma cells (50  –  80%) was also 
positive for EBER transcripts (  Fig. 2, C and F  , insets), whereas 
no EBER  +   cells with the morphological features of neurons, 
glial, endothelial cells, or meningeal fi  broblasts were detected. 
  We next extended the analysis of EBERs to less infi  ltrated 
brain specimens from 12 MS cases with relapsing-remitting, 
progressive relapsing, primary progressive, and secondary pro-
gressive clinical courses (Table S1). Compared with EBV-
high MS cases, fewer, often isolated, perivascular EBER  +   cells 
were present in demyelinated lesions and/or meninges from 
11 of these 12 MS cases (termed EBV-low) (Figs. 2, G  –  I, and   3  ). 
In one case only, two B cell follicles with EBER  +   cells were 
identifi  ed in the meninges despite negligible parenchymal 
infl  ammation. Of note, the only EBV    −    MS case identifi  ed 
in this series (MS80 in Table S1) contained largely inactive 
lesions and no B cells/plasma cells in the brain tissue blocks 
analyzed, supporting a relationship between B cells, EBV 
gene expression, and infl  ammatory activity. The absence of 
EBV-infected in cells in immunologically silent, demyelinated 
  Detection of EBV-encoded small nuclear mRNA (EBER) 
transcripts in B cells and plasma cells infi  ltrating 
the MS brain 
  Using in situ hybridization, brain sections of eight MS cases 
with B cell/plasma cell  –  rich infi  ltrates and ectopic B cell fol-
licles (Table S1, available at http://www.jem.org/cgi/content/
full/jem.20071030/DC1) were stained for EBER transcripts, 
which are predominantly expressed during the latent phase 
of viral infection (  11  ). Substantial accumulation of EBER  +   
cells was noted in the meninges, with maximal enrichment 
in ectopic follicles (  n   = 15) and in the perivascular cuff  s of 
acute (  n   = 4) and chronic active (  n   = 16) white matter 
lesions of all MS cases analyzed (hereafter termed EBV-high) 
(  Figs. 2, A  –  E,   and   3  ).   Less frequently, some EBER  +   cells 
were found sparsely distributed in the lesioned parenchyma, 
particularly in the areas of plasma cell infi  ltration (  Fig. 2, 
E and F  ). No or only occasional EBER  +   cells were present 
in inactive white matter lesions and outside demyelinated 
areas; none was found inside the cortical gray matter. In all 
brain sections examined, EBER signals were confi  ned to the 
cell nuclei, similarly to what was observed in a control, EBV-
asso  ciated B cell lymphoma (  Fig. 2 J  ). No EBER signals 
were detected in the B cell areas of a normal lymph node 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20071030/DC1). 
  By combining in situ hybridization for EBER with immuno-
histochemistry for the pan B cell marker CD20, 70  –  90% of 
EBER  +   cells were identifi  ed as B cells, whereas 40  –  90% of 
  Figure 1.     Immunohistochemical characterization of ectopic B cell follicles with germinal center  –  like features in the cerebral meninges of a 
subset of MS cases with secondary progressive disease. (A) Localization of an ectopic B cell follicle (asterisk) and a sparse infl  ammatory infi  ltrate in the 
subarachnoid space lined by the pial membrane (arrows) at the entrance of a cerebral sulcus (hematoxylin counterstaining; CD20 immunostaining in the 
inset). The adjacent cortical gray matter is extensively demyelinated, as indicated by loss of MOG immunoreactivity. (B  –  D) An ectopic B cell follicle located 
in the depth of a cerebral sulcus is shown that comprises the following: aggregated CD20  +   B cells and a network of stromal/follicular dendritic cells ex-
pressing CXCL13 (B, double immunofl  uorescence staining for CD20 and CXCL13); proliferating B cells (C, double immunofl  uorescence staining for CD20 
and the proliferation marker Ki67; the inset shows three double labeled CD20  + /Ki67 +   cells at higher magnifi  cation); and peripherally located Ig  +   plasma 
cells (D). Immunostainings shown in B  –  D were performed in serial brain sections. (E  –  G) Different ectopic follicles are shown that contain the following: 
numerous cells expressing AID (E); fewer apoptotic cells expressing activated caspase-3 (F); and numerous cells expressing the antiapoptotic molecule 
bcl-2 (G). Perivascular bcl2  +   cells in a white matter lesion (inset in G) and proliferating CD20  +   B cells (arrows) in a large perivascular cuff of an acute lesion 
(H, double immunofl  uorescence staining for CD20 and Ki67) are shown. Bars: A, B, D  –  F, and H, 50     m; C, G, and inset in G, 20     m; inset in C, 10    m.   2902 EBV IN MULTIPLE SCLEROSIS | Serafi  ni et al.
meninges, but none was positive for EBER transcripts (Fig. S1). 
No EBER signals were detected in the brain of two non-
neurological control cases, one case with Alzheimer  ’  s disease, 
and one case with non-EBV  –  related lymphoblastic leukemia 
(Table S1 and Fig. S1). 
  The above fi  ndings demonstrate that abnormal accumu-
lation of EBV-infected cells in the CNS is a common feature 
of MS and is not linked to any particular disease course or 
other parameter, including gender, age at onset, disease dura-
tion, and immune suppressive therapy (Table S1). 
  Expression of EBV latent and lytic proteins in B-cells/
plasma cells infi  ltrating the MS brain 
  We further analyzed the status of EBV infection in the MS 
brain using immunohistochemical techniques with antibodies 
lesions may suggest that in those brain regions a more robust 
EBV infection has occurred at earlier stages of the disease and 
that infected cells have been eliminated. The identifi  cation of 
EBV-infected cells as predominantly B cells was confi  rmed 
by the existence of a positive correlation between the number 
of EBER  +   and CD20  +   cells counted in serial brain sections of 
all the MS cases analyzed (  Fig. 2 K  ). 
  To exclude that infl  ammation could act as a nonspecifi  c 
trigger for the recruitment of EBV-infected B cells/plasma 
cells in the CNS, we performed in situ hybridization for 
EBER in autopsy brain specimens from seven cases with other 
neuroinfl  ammatory diseases (two primary cerebral vasculitis, 
two viral encephalitis, two mycotic meningitis, and one enceph-
alopathy with unknown etiology; Table S1). Each of these 
cases had B cell infi  ltrates in the brain parenchyma and/or 
  Figure 2.     Detection of EBER  +   cells in the MS brain by in situ hybridization. (A  –  E) EBV-high MS cases. In situ hybridization for EBER shows enrich-
ment of EBER  +   cells (blue-black nuclei) in ectopic B cell follicles located in the meninges of two different MS cases (A and B). Combined in situ hybridiza-
tion for EBER and immunostaining for CD20 (red surface staining) reveals a high frequency of EBER  +   B cells in an ectopic B cell follicle (C) and a lower 
percentage of B cells expressing EBER in the large perivascular cuff of an acute white matter lesion (D; the same lesion stained for CD20 and Ki67 in an 
adjacent section is shown in Fig. 1 H). In the insets in C and D, an EBER  + /CD138 +   plasma cell and an EBER  + /CD20 +   B cell are shown, respectively, at higher 
magnifi  cation. Perivascular EBER  +   (E),  CD20 +   B cells (inset in E), and CD138  +   plasma cells (F) in a large periventricular white matter lesion (E), and some 
intraparenchymal infi  ltration by EBER  +   cells (E) and plasma cells (F) in the same region. The inset in F shows CD138  +   plasma cells positive for EBER inside 
the parenchyma. (G  –  I) EBV-low MS cases. EBER  +   cells in the meninges (G) and around scarcely infi  ltrated blood vessels (H and I) in chronic active white 
matter lesions. The insets in G and I show CD20 immunostaining of the corresponding areas in adjacent sections. In situ hybridization for EBER in a con-
trol, EBV-associated B cell lymphoma (J). Bars: A  –  C, E, G, J, and insets in E, G, and I, 50     m; D and F, 20     m; insets in C, D, and F, 10     m. (K) Statistically 
signifi  cant correlation between the number of CD20  +   and  EBER +   cells in the white matter (left) and meninges (right) of EBV-low (  n   = 12) and EBV-high (  n   =  8) 
MS cases. EBER  +   and  CD20 +   cells were counted as described in Materials and methods.     JEM VOL. 204, November 26, 2007 
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is expressed in the early phases of the EBV replicative cycle 
and is regulated by two transactivator proteins, ZEBRA and 
RTA (  49  ). A high frequency of BFRF1  +   cells was observed 
inside and around all intrameningeal B cell follicles analyzed 
(  Fig. 4, G  –  I  , and Table S1), indicating that these structures 
represent main sites of viral reactivation. No BFRF1 immuno-
reactivity was found in the B cell areas of a control, normal 
lymph node (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20071030/DC1). Double immunostainings 
showed that BFRF1 immunoreactivity was present in a sub-
stantial proportion of intrameningeal B cells and plasma cells 
(30  –  55%) but was much stronger in plasma cells than in B 
cells (  Fig. 4, H  –  J  ), in agreement with fi  ndings in healthy car-
riers where terminal diff  erentiation into plasma cells initiates 
the viral replicative cycle (  13  ). Some BFRF1  +   cells (mainly 
plasma cells) were also detected in the large perivascular cuff  s 
of two acute lesions in two EBV-high MS cases (  Fig. 4, K  –  M  ), 
but not in chronic active lesions, indicating a relationship be-
tween viral reactivation and acute infl  ammation. 
  To evaluate the expression of structural EBV proteins, 
we stained MS brain sections with an antibody specifi  c for 
gp350/220, the most abundant glycoprotein of the viral en-
velope, which is expressed on the membrane of EBV-infected 
cells (positive control staining is shown in Fig. S2). Except for 
two occasional gp350/220  +   cells observed in one EBV-high 
MS case, no gp350/220 immunoreactivity was detected in the 
brain sections of 17 EBER  +   MS cases analyzed (Table S1), 
indicating abortive EBV replication. 
  Widespread intracerebral EBV reactivation in acute MS 
  To test the idea that an acute clinical course, which is ex-
tremely rare in the MS population, might be associated 
with more robust EBV reactivation in the CNS, and to ex-
clude the possibility that our fi  ndings are only relevant to the 
late chronic stages of MS, we investigated the distribution 
of EBV latent and lytic markers in cerebral brain sections 
from two MS cases with disease durations of 23 d and 10 mo 
(MSG9 and MSH6, respectively, in Table S1). Both cases had 
very severe pathology with extensive myelin loss in the peri-
ventricular regions of the cerebral hemispheres, multiple ac-
tively demyelinating lesions at all CNS levels (not depicted), 
and prominent B cell infi  ltration (  Fig. 5 D  ).   The menin-
ges, when preserved, were scarcely or not at all infi  ltrated 
(not depicted). In situ hybridization for EBER could not 
be performed in the acute MS cases because of the long 
tissue fi  xation time in formalin. However, by immunohisto-
chemistry, accumula  tion of LMP1  +  , but not of EBNA2  +  , 
cells was noted in all perivascular cuff  s containing B cells, 
indicating expression of the latency default program (  Fig. 
5, A and B  ). Notably, numerous cells expressing the early 
lytic cycle  –  associated protein BFRF1 were present in large 
intraparenchymal perivascular cuff  s (  Fig. 5, D  –  F  ) as well as 
around small blood vessels disseminated throughout the 
white matter, and less frequently inside the parenchyma 
(  Fig. 5, H  –  J  ). A few isolated cells (three to fi  ve cells/section) 
expressing the gp350/220 and the viral capside protein p160 
against latent and lytic viral proteins. As markers of viral 
  latency, we studied EBNA2 and LMP1. EBNA2 is the fi  rst 
viral protein to be expressed in EBV-infected cells in vitro 
and acts as a transactivator that regulates the expression of 
viral and cellular genes involved in the initiation and mainte-
nance of cell proliferation (growth program) (  10, 11  ). LMP1 
is an integral membrane protein that is expressed during the 
growth and default programs of EBV infection, acts as a con-
stitutively acting mimic of CD40, a key receptor for B cell 
activation, and inhibits B cell apoptosis by up-regulating the 
expression of antiapoptotic molecules (  10, 11  ). EBNA2  +   and 
LMP1  +   cells were detected perivascularly in active white 
matter lesions and in the meninges in 13 and 16 of 18 EBV  +   
MS cases analyzed, respectively (Table S1), the highest fre-
quency being observed in EBV-high MS cases (  Fig. 4, A  –  F  ).   
Ectopic B cell follicles contained numerous LMP1  +   (  Fig. 4 D  ), 
but no EBNA2  +   cells (not depicted). This pattern of EBV gene 
expression is reminiscent of that observed in tonsillar germinal 
center and memory B cells of healthy EBV carriers where the 
virus expresses the default program, shutting off   EBNA2 
but still expressing LMP1 (  12  ). Consistent with the absence of 
EBER transcripts, no EBNA2 and LMP1 immunoreactivity 
was detected in the brain tissue of cases with other infl  amma-
tory neurologic diseases (Table S1). 
  We then searched for evidence of EBV lytic replication in 
the MS brain. The lytic program consists of the sequential ac-
tivation of three distinct classes of viral genes: immediate early, 
early, and late. BFRF1, a recently identifi  ed lytic protein (  48  ), 
  Figure 3.     Quantifi  cation of CD20  +  , EBER  +  , and CD8  +   cells in MS 
brain sections. MS cases with high and low brain infl  ammation were a 
posteriori classifi  ed as EBV-high and EBV-low, respectively. The graphs 
show signifi  cant differences between the two groups in the number of 
CD20  + ,  EBER +  , and CD8  +   cells counted in the white matter (A) and menin-
ges (B). Dot points represent values for each MS case. Each value repre-
sents the mean of cell counts performed as described in Materials and 
methods. The bars represent median values for each group (  n   = 12 for 
EBV-low MS cases;   n   = 8 for EBV-high MS cases).     2904 EBV IN MULTIPLE SCLEROSIS | Serafi  ni et al.
  OCBs, which are generally CSF restricted and relatively 
constant throughout the disease (  42  ), were found in the CSF 
of 15 of 16 MS cases. Interestingly, the number of CSF OCBs 
was signifi  cantly higher (P = 0.0079) in EBV-high MS cases 
(  Fig. 6 A  ), supporting a relationship between EBV infection 
and intracerebral B cell expansion and activation.   Consistent 
with previous fi  ndings (  27, 28  ), EBV-specifi  c OCBs were 
detected in some MS cases (7 of 16), but showed no prefer-
ential distribution in the EBV-high and EBV-low MS groups 
(  Fig. 6 B  ). Except for one case, EBV-specifi  c OCBs, when 
present, were few (median number, 2; range, 1  –  5) and gen-
erally faint (  Fig. 6 C  ), indicating that persistent EBV infection 
in the MS brain does not yield a robust, virus-specifi  c oligo-
clonal humoral response that is typical of CNS infections as-
sociated with viral replication (  50  ). 
  Expansion and cytotoxic activity of CD8  +   T cells at sites 
of accumulation of EBV-infected cells in the MS brain 
  Because cytotoxic CD8  +   T cells have a key role in control-
ling latent EBV infection and in preventing viral replication 
(  14  ), we next investigated the distribution and activation of 
CD8  +   T cells and their relationship with EBV-infected B 
were also present in the meninges and white matter lesions of 
both acute MS cases (  Fig. 5, L  –  N  ), indicating viral replica-
tion, albeit at a low level. These fi  ndings suggest that seed-
ing of the brain by EBV-infected cells is an early event in MS, 
and that widespread EBV reactivation in the white matter is 
asso  ciated with dramatic infl  ammatory tissue destruction and 
fast neuro  logical deterioration. 
  Analysis of EBV DNA and of total and EBV-specifi  c 
oligoclonal IgG in the MS CSF 
  We next investigated whether the frequency of EBV-infected 
cells and the status of EBV infection in the MS brain corre-
lated with viral load and oligoclonal IgG bands (OCBs) in the 
corresponding postmortem CSF. This set of analyses included 
16 MS cases with a relapsing-remitting or progressive clinical 
course (9 EBV-low and 7 EBV-high). Using real-time PCR, 
EBV DNA was generally undetectable, being found at low 
copy number in the CSF of only 2 of 16 MS cases (2 primary 
progressive MS with 1,310 and 4,900 copies/ml, respectively). 
None of the other viruses investigated (HSV-1/2, varicella-
zoster virus, CMV, human herpesvirus 6 [HHV-6], and JC 
virus) was detected in the 16 CSF samples analyzed. 
  Figure 4.     Detection of EBV latent and early lytic proteins in the MS brain. In brain sections from EBV-high MS cases, cells expressing EBNA-2 
(nuclear staining) are present in the perivascular infl  ammatory cell infi  ltrates in acute (A) and chronic active (B) white matter lesions. LMP1  +   cells 
(membrane staining) in a sparse meningeal infi  ltrate (C) and in an intrameningeal ectopic B cell follicle (D; the inset shows the same follicle stained 
for EBER in an adjacent section) from EBV-high MS cases. Perivascular EBNA2  +   and  LMP1 +   cells in chronic active lesions from an EBV-low MS case are 
shown in E and F, respectively. High frequency of BFRF1  +   cells in an ectopic intrameningeal B cell follicle from an EBV-high MS case (G). In two differ-
ent ectopic B cell follicles (H and I), double immunofl  uorescence for CD20 and BFRF1 shows that BFRF1 is expressed in a substantial proportion of 
CD20  +   B cells, but its intensity is much stronger in CD20   −    cells (arrows). The insets in G and H highlight the typical perinuclear localization of BFRF1. 
Double immunofl  uorescence for Ig and BFRF1 shows that the lytic cycle  –  associated protein is strongly expressed in a proportion of Ig  +   plasma 
cells in the same ectopic follicle shown in I (J) and in a large perivascular cuff in an acute lesion of an EBV-high MS case (K). Two double-labeled 
Ig  + /BFRF1 +   plasma cells are shown at high power magnifi  cation (L and M). Bars: K and inset in D, 50     m; A  –  J and inset in B, 20     m; L, M, and insets 
in G and H, 5    m.   JEM VOL. 204, November 26, 2007 
ARTICLE
2905
T cell biological responses that follow sustained antigenic 
stimulation. We also noted that several CD8  +   T cells in the 
highly infi  ltrated MS brains had an activated lymphoblastoid 
morphology with cytoplasmic protrusions that contacted B 
cells and, more frequently, plasma cells and BFRF1  +   cells 
(  Fig. 7, E  –  G  ). By double immunostaining for CD8 and the 
lytic protein perforin, we found that 70  –  80% of the cells 
expressing perforin were CD8  +   T cells, and that     3% of 
the CD8  +   T cells were perforin  +  . Approximately 30% of the 
perforin-expressing cells showed polarization of perforin gran-
ules toward a target cell (  Fig. 7 H  ), which was in most cases 
identifi  ed as a plasma cell (  Fig. 7, I  –  K  ). This observation, to-
gether with the fi  nding that a few CD8  +   T cells infi  ltrating 
the MS brain displayed membrane expression of CD107a 
(  Fig. 7, L and M  ), a component of cytotoxic granules that 
is exposed onto the cell surface after release of lytic granule 
contents (  51  ), supports an ongoing cytotoxic activity at sites 
of EBV infection. 
  Consistent with the idea that an antiviral immune re-
sponse occurs in the MS brain, blood dendritic cell antigen 2  +   
plasmacytoid dendritic cells, which are the main source of 
type I IFN and have a key role in antiviral immunity (  52  ), 
were detected in many MS immune infi  ltrates. The highest 
cells/plasma cells in the MS brain. We found that the number 
of CD8  +   T cells accumulating in MS meninges and white 
matter lesions was signifi  cantly higher in EBV-high than in 
EBV-low MS cases (  Fig. 3  ), and that CD8  +   T cells infi  ltrated 
all sites where virally infected B cells/plasma cells were lo-
cated, including ectopic B cell follicles (  Fig. 7, A and B  ).   In 
addition, the frequency of CD8  +   T cells strikingly correlated 
with that of EBER  +   cells (  Fig. 7 N  ). The highest frequency 
of CD8  +   T cells was observed in the large intraparenchymal 
perivascular cuff  s of EBV-high MS cases (  Fig. 7 B  ). Promi-
nent accumulation of CD8  +   T cells was also observed in active 
lesions of the two acute MS cases, matching the distribution 
of EBV-infected cells (  Fig. 5, C, G and K  ). 
  Four EBV-high MS cases were analyzed for expression of 
CD8  +   T cell activation markers and cytotoxic activity. We 
observed that the proliferation antigen Ki67 was expressed in 
a small percentage (2  –  3%) of CD8  +   T cells accumulating in 
active intraparenchymal lesions and ectopic follicles (  Fig. 
7 C  ). Moreover, immunoreactivity for IFN-     was detected 
in the cytoplasm of a discrete proportion (10  –  20%) of brain-
infi  ltrating leukocytes (  Fig. 7 D  ), many of which (60  –  80%) 
were identifi  ed as CD8  +   T cells by double immunostaining 
(  Fig. 7 D  , insets). These fi  ndings indicate activation of CD8  +   
  Figure 5.     Diffuse infi  ltration of latently and lytically EBV-infected cells in the brain of acute MS cases. (A and B) Presence of LMP1  +   cells 
around scarcely infl  amed blood vessels throughout an active lesion of one acute MS case (MSG9; disease duration 23 d). In the same area, perivascular 
accumulation of CD8  +   T cells is observed (C). A highly infi  ltrated lesion in the white matter of the second acute MS case examined (MSH6; disease dura-
tion 10 mo) contains large B cell  –  enriched perivascular cuffs (D). Immunostainings for BFRF1 and CD8 in adjacent sections show the presence of numer-
ous perivascular BFRF1  +   cells (E and F) and CD8  +   T cells (G) in the same area. The blood vessels labeled with asterisks in D are shown at high power 
magnifi  cation in E, F, and G. The inset in E shows the typical perinuclear localization of BFRF1. Sparse infi  ltration of BFRF1  +   cells in the white matter of 
case MSH6 is shown (H). Perivascular (I) and intraparenchymal (J) BFRF1  +   cells are shown at high power magnifi  cation. Staining of an adjacent section 
with anti-CD8 mAb shows diffuse infi  ltration of CD8  +   T cells in the same area (K). Presence of isolated cells expressing the structural viral proteins 
gp350/220 (L and M; membrane staining) and p160 (N; cytoplasmic staining) in the meninges of MSH6 (L and N) and in the white matter of MSG9 (M). 
Bars: D, 200     m; A, F, G, K, and L, 50     m; B, C, E, H, I, M, N, and inset in E, 20     m; J, 10    m.   2906 EBV IN MULTIPLE SCLEROSIS | Serafi  ni et al.
previous studies to detect EBV in the MS brain using in situ 
hybridization for EBER and immunohistochemistry for viral 
proteins (  39, 40  ). 
  The pattern of viral proteins expressed in the brain of 
most MS cases analyzed here is indicative of the growth 
(EBNA2, LMP1) and default (LMP1) programs of EBV la-
tent infection. Because cells expressing EBNA2 and LMP1 
are usually absent in the blood (  10, 11  ), these fi  ndings indi-
cate complete disruption of EBV regulation. This could be due 
to an underlying defect in the immune response or to the 
inability of T cells to eliminate latently infected cells in an 
immune-privileged site, such as the CNS, that is not as readily 
accessible to T cell surveillance. Consistent with a predomi-
nantly latent infection, in the MS CSF the presence of low 
titers of EBV DNA and of a strong, EBV-specifi  c and oli-
goclonal humoral immune response was only occasional. 
However, detection of the early lytic cycle  –  associated pro-
tein BFRF1 in highly infi  ltrated brains of cases with sec-
ondary progressive MS and with acute, fatal MS indicates 
an attempt of EBV to enter the replicative cycle. These fi  nd-
ings raise the possibility that periodic EBV reactivation is 
related to infl  ammatory activity in the brain parenchyma of 
MS patients, as assessed by gadolinium-enhanced magnetic 
resonance imaging (  54  ). Such a scenario would be consis-
tent with the results of a recent study showing higher num-
bers of gadolinium-enhanced lesions in relapsing-remitting 
MS patients with stable levels of serum IgG specifi  c for EBV 
early antigens (which are considered markers of EBV reac-
tivation) as compared with early antigen seronegative MS 
patients (  55  ). 
  In MS patients, the intracerebral pool of virus-harboring 
B cells could be maintained by several mechanisms, including 
migration of infected B cells from the blood circulation, virus-
driven B cell proliferation, and, perhaps, also local shedding 
of low numbers of viral particles due to occasional viral 
replication. B cells normally do not migrate into the CNS 
tissue and represent only a minority of the lymphocytes cir-
culating through the CSF in physiological conditions. How-
ever, antigen-stimulated memory B cells (  56  ) and abnormally 
activated B cells, including EBV-infected B cells (  57  ) and 
malignant B cells (  58  ), may home to the CNS through mech-
anisms that probably involve B cell  –  attracting chemokines, 
such as CXCL12 and CXCL13 (  58, 59  ). Expression of the 
latency proteins EBNA2 and LMP1, both of which provide 
proliferative and prosurvival signals to B cells (  10  ), and 
the presence of foci of B cell proliferation in the MS brain 
support a mechanism of EBV-driven B cell expansion. At 
advanced stages of the disease (secondary progressive MS), 
EBV-infected activated B cells may be induced to organize 
themselves into B cell follicles, thereby allowing viral persis-
tence through exploitation of the B cell maturation process 
that takes place therein (  12, 13  ). The question remains as to 
which antigens are involved in the activation of B cells un-
dergoing germinal center reactions in ectopic follicles, or if 
EBV, through expression of the latency proteins LMP1 and 
LMP2a, which simulate activation of the CD40 receptor and 
frequency of plasmacytoid dendritic cells was found in intra-
meningeal B cell follicles and active lesions of EBV-high MS 
cases (Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20071030/DC1). Prominent macrophage activation 
was also associated with intracerebral accumulation of EBV-
infected cells and CD8  +   T cells (not depicted). 
    DISCUSSION   
  Although an association between EBV and MS has been pro-
posed for nearly 30 yr (  15, 53  ), the mechanisms linking EBV 
infection to MS immunopathology have remained elusive. 
By analyzing postmortem brain tissue from MS cases with 
diff  erent disease courses, we show that accumulation of EBV-
infected B cells/plasma cells in the meninges and perivascular 
compartment of white matter lesions is a common feature 
of MS and that the frequency of EBV-harboring cells cor-
relates with the degree of brain infl  ammation. The absence 
of EBV in brain-infi  ltrating B cells in other infl  ammatory 
neurological diseases indicates that homing of EBV-infected 
B cells to the CNS is specifi  c to MS and not a general phe-
nomenon driven by infl  ammation. The other major fi  nding 
of this study is that ectopic B cell follicles forming in the 
cerebral meninges of MS cases with secondary progressive 
disease are main sites of EBV persistence, substantiating a 
direct link between EBV infection and B cell dysregulation 
in MS. Methodological diff  erences, as well as poor tissue pres-
ervation and absence of relevant infl  ammatory activity in the 
brain tissue blocks analyzed, may explain the failure of two 
  Figure 6.     Analysis of total and EBV-specifi  c OCBs in postmortem 
CSF from MS cases. The graphs show (A) signifi  cantly higher numbers 
of OCBs in the CSF of EBV-high MS cases (  n   = 7) versus EBV-low MS 
cases (  n   = 9) and (B) no difference in the number of EBV-specifi  c OCBs 
between EBV-high and EBV-low MS cases. Dot points represent values for 
each MS case, and the bars represent median values for each group. 
p-values, calculated by the Mann-Whitney   U   test, are indicated where 
statistically signifi  cant. (C) Affi  nity-mediated immunoblotting on EBV 
antigen-coated nitrocellulose paper of isoelectrofocused CSF from two 
EBV-low MS cases (lanes 1 and 2 correspond to MS154 and MS102 in 
Table S1, respectively), anti-EBV EA-D monoclonal (mo) antibody used as 
positive control (lane 3), and serum (ser) from a patient with monoclonal 
IgG used as control for binding specifi  city (lane 4). An additional control 
for binding specifi  city included CSF from the MS102 case that was blotted 
onto casein-coated nitrocellulose paper (absence of reactivity; lane 5). 
Faint (lane 1) and both faint and strong (lane 2) EBV-specifi  c OCBs are 
present in MS154 and MS102 cases, respectively (arrows indicate OCBs). 
Of note, MS102 was also positive for EBV DNA and had the highest fre-
quency of EBER  +   and  CD8 +   cells in white matter lesions and meninges 
among the EBV-low MS cases.     JEM VOL. 204, November 26, 2007 
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clinical onset suggests an involvement of EBV early in MS 
pathogenesis (  24, 25  ). Such an early increase in anti-EBNA 
antibodies could be related to EBV spread in the CNS, which 
probably occurs long before clinical manifestations of MS. 
Furthermore, the fact that the risk of developing MS increases 
with infectious mononucleosis (  20  –  22  ) suggests that a higher 
frequency of circulating infected B cells can predispose to viral 
invasion of the CNS and/or to immune hyperreactivity to EBV 
resulting in an immunopathologic response. The numerous 
similarities between epidemiology of MS and infectious 
mononucleosis, including occurrence in young adults, similar 
latitude gradient distribution, association with late EBV infec-
tion, increased frequency in individuals with high socio-
economic status, and earlier onset in women than in men, 
strengthen the concept that EBV infection is implicated in MS 
etiology (  5  ). The demonstration of an abnormal accumulation 
B cell receptor, respectively (  10  ), can make latently infected 
B cells potentially independent of T cell help and/or antigen. 
Viral reactivation, which was found to be predominantly as-
sociated with ectopic B cell follicles and acute MS lesions, 
most likely occurs as a consequence of B cell diff  erentiation 
into Ig-producing plasma cells (  13  ). The latter may be pro-
moted by interactions between viral factors and infl  ammatory 
cytokines, like B cell  –  activating factor of the tumor necrosis 
factor family, which cooperates with LMP1 in inducing T 
cell  –  independent Ig heavy chain class switching (  60, 61  ), and 
type I IFN and IL-6 released by activated plasmacytoid den-
dritic cells (  62  ). 
  To date, the strongest evidence for a causative role of 
EBV in MS comes from sero-epidemiological studies (  4, 5  ). 
Particularly, the marked increase in serum antibody titers to 
EBV antigens (mainly EBNA complex) several years before 
  Figure 7.     CD8  +   T cell activation and interaction with EBV-infected cells in the brain of EBV-high MS cases. Double immunofl  uorescence 
for CD8 and CD20 (A) and for CD8 and Ig (B) shows accumulation of CD8  +   T cells in an intrameningeal ectopic B cell follicle (A) and in the perivascu-
lar cuff of an acute white matter lesion (B; same infi  ltrated blood vessel stained for BFRF1 in an adjacent section is shown in Fig. 4 K). The perivascu-
lar infi  ltrate shown in B contains numerous Ki67  +   proliferating cells, of which some are CD8  +   T cells (arrows) (C). Note the small cluster of three 
Ki67  + /CD8 +   cells shown at higher magnifi  cation in the inset in C. Immunohistochemistry with anti  –  IFN-     antibody (D) reveals strong immunoreactiv-
ity (brown staining) in the cytoplasm of numerous cells in an intrameningeal B cell follicle (same follicle double stained for EBER and CD20 in Fig. 2 C). 
The insets in D show double stainings for CD8 (brown) and IFN-     (purple).  IFN-   + /CD8 +   cells (black arrows), as well as cells single stained for either 
CD8 (white arrow) or IFN-     (arrowheads), are identifi  ed in the same follicle (lower inset). Two IFN-    +   cells, one positive (arrow) and one negative 
(arrowhead) for CD8, are shown in the upper inset. Double immunofl  uorescence stainings for CD8 and CD20 (E), CD8 and Ig (F), and CD8 and BFRF1 
(G) show that CD8  +   T cells with an activated, lymphoblastoid morphology cluster around and extend cytoplasmic processes that contact CD20  +   B 
cells, Ig  +   plasma cells, and BFRF1  +   cells, respectively. Double immunostaining for perforin and CD8 shows the presence of perforin granules in 
two out of several CD8  +   T cells accumulating in the perivascular cuff of a chronic active lesion (H). Polarization of perforin granules is evident in 
one CD8  +   T cell (arrow), but not in the other (arrowhead). Double immunostaining for perforin and Ig (I and J; inflamed meninges) or CD20 
(K; intralesional perivascular cuff) shows polarization of perforin granules toward two Ig  +   plasma cells, but not toward CD20  +   B cells. Double immuno-
staining for CD8 and CD107a (L and M) reveals surface distribution of CD107a in some CD8  +   T cells (arrows) accumulating in the meninges (L) and in 
an intraparenchymal perivascular cuff (M). Note the presence in the same microscopic fi  elds of CD8  +   T cells that do not express CD107a (arrowheads 
in L and M) and of a CD8   −    cell with a cytoplasmic distribution of CD107a (asterisk in M) . Bars: A  –  C, 50     m; D, G, M, and inset in C, 20     m; E, F, H  –  L, 
and lower inset in D, 10     m; upper inset in D, 5     m. (N) Statistically signifi  cant correlation between the number of CD8  +   and  EBER +   cells in the white 
matter (left) and meninges (right) of EBV-low (  n   = 12) and EBV-high (  n   = 8) MS cases. EBER  +   and  CD8 +   cells were counted as described in Materials 
and methods.     2908 EBV IN MULTIPLE SCLEROSIS | Serafi  ni et al.
of viral antigens by dendritic cells present in MS-immune in-
fi  ltrates probably plays a major role in the expansion and acti-
vation of EBV-specifi  c CD8  +   T cells (  66, 67  ). This scenario 
would provide an explanation for the dominance and persis-
tence of CD8  +   T cell clones in MS lesions, as revealed by 
CDR3 spectratyping analysis (  68, 69  ), and is consistent with 
the presence of EBV-specifi  c CD8  +   T cells in the CSF of MS 
patients (  30  ). 
  CD8  +   T cell  –  mediated immunopathology is the major 
determinant of tissue destruction in EBV-associated diseases 
(  14  ) and may therefore contribute also to damage of myelin 
sheaths and axons in MS, probably in conjunction with de-
position of antibody-complement complexes in the CNS 
  tissue (  1  ). The observation that in MS T cells, B cells, plasma 
cells, and myeloid and plasmacytoid dendritic cells preferen-
tially accumulate in the meninges and perivascular compart-
ment of white matter lesions (  66  ,   70  , and this study) suggests 
that the immune response targets antigens localized outside 
the neural parenchyma proper and that bystander tissue dam-
age may be mainly caused by cytotoxic molecules diff  using 
from the above sites. This concept is highlighted in   Fig. 1   A, 
which shows extensive myelin loss in the non-infi  ltrated 
  cerebral gray matter adjacent to highly infl  amed meninges 
containing a B cell follicle. 
  Because increased seroprevalence, higher frequency of 
EBV-infected B cells in the blood, and altered immune reac-
tivity to EBV are common to other chronic infl  ammatory 
diseases with dysregulated B cell and autoimmune features, 
including systemic lupus erythematosus and rheumatoid ar-
thritis (RA) (  7  –  9, 71  ), comparison of EBV  –  host interactions 
and analysis of the relationship between EBV-infected cells 
and CD8  +   T cells in aff  ected tissues may provide clues for 
EBV-related, though disease-specific, immunopathologic 
mechanisms. The presence of EBV-infected cells in the RA 
synovium is controversial (  72  ). However, several pathologic 
features in common with the MS brain, such as formation 
of ectopic germinal centers (  73  ) and accumulation of CD8  +   
T cells (  74  ) and plasmacytoid dendritic cells (  75  ), raise the 
suspicion that EBV might be the trigger of B cell abnormal-
ities and immunopathologic response in RA. This possibility 
is currently under investigation in RA and other auto-
immune diseases. 
  Collectively, the strong association of EBV with MS in-
dicated by epidemiological studies (  4, 5  ), the increased EBV-
specifi  c humoral and cellular immune response to EBV in 
MS patients (  6  ), and the present demonstration of a perturbed 
EBV infection in the MS brain provide strong support for 
the idea that EBV has a key role in MS pathogenesis. How-
ever, several questions remain open, particularly what attracts 
EBV-infected B cells and causes viral reactivation in the 
CNS, and if viral factors, coinfections, other environmental 
infl  uences, and genetic factors increase the risk for dysregu-
lated EBV infection in MS. Recently, an allelic variant of the 
gene encoding the interleukin 7 receptor      chain (  IL7R  ) has 
been identifi  ed as a risk factor for MS (  76  –  78  ) and shown to 
infl  uence the amount of soluble and membrane-bound form of 
of EBV-harboring B cells and plasma cells in the MS brain 
further supports this concept. However, it cannot be excluded 
that dysregulated EBV infection in the CNS, rather than be-
ing a primary trigger of MS, might be the consequence of an 
underlying, still unknown, disease process resulting in attrac-
tion of EBV-infected B cells to preexisting CNS lesions. 
In either case, a role for EBV in the initial stages of the disease 
is indicated by the diff  use viral infection observed in the brain 
of acute MS cases. 
  Persistent infection of CNS-infi  ltrating B cells with EBV 
provides a sound explanation for key features of MS pathol-
ogy. Through expansion and activation of latently infected B 
cell clones, EBV would be directly responsible for the persis-
tent intrathecal synthesis of oligoclonal IgG, which is com-
mon to most MS patients (  42  ). This view is supported by 
the demonstration of an increased number of OCBs in the 
CSF of MS cases with a high frequency of brain-infi  ltrating 
EBV-infected B cells and plasma cells. EBV-driven expan-
sion of postgerminal center B cells would also be consistent 
with enrichment of memory B cells and plasma blasts in the 
CSF of MS patients (  63  ), and with the presence in MS 
lesions and CSF of B cell clones showing extensive somatic 
mutations in the Ig variable gene segments (  43  –  45  ). The pat-
tern of CSF OCBs is usually stable over time in MS patients 
(  42  ), suggesting persistence of the same EBV-infected B cell 
clones. To date, the identity of the antigens recognized by 
OCBs has remained elusive. As shown in previous studies 
(  27, 28  ) and confi  rmed here, CSF OCBs specifi  c for EBV can 
be detected in a proportion of MS patients, but their presence 
does not appear to be related to the frequency of EBV-
  infected B cells in the brain tissue. The heterogeneous pattern 
of antibody reactivities toward CNS-restricted and ubiqui-
tous self-antigens and toward infectious agents in the CSF of 
MS patients (  64  ) may refl  ect a random, EBV-driven acti-
vation of B cell clones with diff  erent antigen specifi  cities. 
Interestingly, production of autoantibodies is also a feature 
of infectious mononucleosis (  65  ) and does not necessarily re-
fl  ect a pathogenic immune response if an autoreactive T cell 
response is not induced. 
  One of the main implications of the present fi  ndings is 
that a chronic immune response toward latently and lytically 
infected B cells/plasma cells underlies the continuous recruit-
ment and activation of infl  ammatory cells in the MS brain, 
resulting in an immunopathologic process. Evidence sup-
porting an ongoing antiviral immune response at sites of ac-
cumulation of EBV-infected cells in the MS brain includes: 
(a) existence of a positive correlation between frequency and 
localization of CD8  +   T cells and EBV-infected B cells/plasma 
cells; (b) presence of CD8  +   T cells showing features of anti-
gen-induced activation, such as proliferation, IFN-     produc-
tion, polarization of perforin granules, and surface expression of 
the degranulation marker CD107a, the latter two suggesting 
cytotoxicity; (c) establishment of direct interactions between 
CD8  +   T cells and B cells/plasma cells, the latter apparently 
being the preferential target of a cytotoxic response; and (d) 
recruitment of plasmacytoid dendritic cells. Cross-presentation JEM VOL. 204, November 26, 2007 
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The binding of biotinylated secondary antibodies was visualized with avidin-
biotin horseradish peroxidase or alkaline phosphatase complex technique 
(ABC Vectastain Elite and Standard ABC-AP kit; Vector Laboratories) 
and 3,3    -diaminobenzidine containing 0.01% H  2  O  2   as substrate or Fast 
Red (Sigma-Aldrich), respectively. All sections were counterstained with 
hematoxylin and analyzed as described above. Negative controls included 
the use of IgG isotype controls or preimmune serum, or omission of the 
primary antibody. 
  Indirect immunofl  uorescence and confocal analysis.     After an initial 
blockade with 10% normal sera in PBS, sections were incubated overnight 
at 4  °  C with unconjugated primary antibodies specifi  c for CD8, CD20, 
Ig-A,-G,-M, Ki67, CXCL13, perforin, CD107a, or BFRF1, or with fl  uores-
cein-conjugated anti  –  Ig-A,-G, -M antibody (Table S2), alone or in diff  erent 
combinations. Sections were then incubated for 1 h at room temperature 
with fl  uorochrome-conjugated secondary antibodies and sealed in Vecta-
shield (Vector Laboratories). For negative controls, primary antibodies were 
replaced with preimmune serum and IgG isotype controls. Images were ana-
lyzed and acquired with a laser scanning confocal microscope (LSM 5 Pascal; 
Carl Zeiss, Inc.). Further details about immunohistochemical and indirect 
immunofl  uorescence procedures are given in the Supplemental Materials 
and methods. 
  Quantitative analysis.     The number of EBER  +  , CD20  +  , and CD8  +   cells 
was counted in six adjacent sections per tissue block (two 2   ×   2-cm sections 
were analyzed for each immunohistochemical staining) at 20  ×   by one inves-
tigator (B. Serafi  ni) blinded to the case number. One to two blocks per MS 
case were analyzed. Values are expressed as the mean number of positive cells 
per mm  2   in the white matter and per mm in the meninges. 
  Viral DNA detection.     Using the TaqMan technology (  79  ), CSF samples 
were tested by real-time PCR for DNA of the following viruses: EBV, 
HSV-1, HSV-2, varicella-zoster virus, CMV, HHV6-A, HHV6-B, and JC 
virus, as described in the Supplemental Materials and methods. PCR primers 
and protocols are listed in Table S3, which is available at http://www.jem
.org/cgi/content/full/jem.20071030/DC1. 
  Isoelectric focusing immunoblot.     The pattern of OCBs in autopsy CSF 
was investigated with agarose isoelectric focusing, pH 3.0  –  10.0 (Cambrex), 
and affi   nity immunoblotting using a standard protocol (  80  ). Although the 
lack of paired serum samples, which were not available at autopsy, inherently 
aff  ected the CSF analysis, in MS OCBs are typically restricted to the CSF, 
without corresponding serum bands (  42  ). IgG and albumin were determined 
with turbidimetry (Cobas Integra). EBV-specifi  c OCBs were determined 
using a previously published isoelectric focusing/affi   nity-mediated immuno-
blotting protocol (  80  ), using nitrocellulose membranes that had been previ-
ously coated with highly pure EBV antigen (strain P3HR1), which contains 
all viral antigens, and a mouse monoclonal anti-EBV EA-D IgG as a positive 
control (both from Fitzgerald Industries International). The serum of a pa-
tient with a monoclonal gammapathy tested on EBV-precoated papers and 
EBV-specifi  c OCB  +   CSF samples tested on lanes coated with a blocking 
  solution  –  containing casein (WesternBreeze; Invitrogen) only were used for 
assessing nonspecifi  c binding. For each sample, 0.3     g IgG was used. 
  Statistical analysis.     The Mann-Whitney   U   test was used to compare the 
median values of EBER  +  , CD20  +  , and CD8  +   cells counted in adjacent MS 
brain sections and of CSF OCBs between EBV-low and EBV-high groups 
of MS cases. Spearman  ’  s rank correlation was calculated to analyze the rela-
tionship between the number of EBER  +   cells and the number of CD20  +   or 
CD8  +   T cells in MS brain sections. A p-value lower than 0.05 was consid-
ered signifi  cant. 
  Online supplemental material.     Materials and methods for tissue process-
ing and immunohistochemistry, and PCR protocols for viral DNA detec-
tion in the CSF are included in the supplemental material. Supplemental 
the receptor (  77  ). In light of the present fi  ndings, this asso-
ciation is particularly intriguing because the IL-7  –  IL-7R 
pathway controls proliferation and survival of B cells and T 
cells, and is essential for the development and maintenance 
of memory T cells. It is envisaged that a better understand-
ing of EBV  –  host interactions in susceptible individuals will 
be relevant for the design of new preventive and therapeutic 
strategies for MS. 
  MATERIALS AND METHODS 
  Postmortem brain tissue specimens and CSF.     This study was per-
formed on postmortem brain tissue from 22 MS patients, 7 patients with 
other infl  ammatory neurological diseases, 2 control patients without neuro-
logical disease, 1 patient with Alzheimer  ’  s disease, and 1 patient with non  –
  EBV-related lymphoblastic leukemia. Patient details, including treatment 
status, are given in Table S1. MS brain and control tissue specimens were 
provided by the UK Multiple Sclerosis Tissue Bank at Imperial College 
London (confi  rmation of MS diagnosis provided by Drs F. Roncaroli and R. 
Nicholas), the Department of Neurosciences, Ophthalmology and Genetics, 
University of Genova, Italy, and the Institute of Pathological Anatomy, U.
C.S.C. Policlinico A. Gemelli, Rome, Italy. The two acute MS cases were 
provided and characterized by J.W. Prineas (University of Sydney, Sydney, 
Australia). Tissue processing is described in the Supplemental Materials and 
methods. The postmortem delay ranged between 7 and 27 h (median time, 
18 h). This study was approved by the Ethics Committee of the Istituto 
Superiore di Sanit  à  . 
  For the MS cases, 34 tissue blocks (2   ×   2 cm) from the cerebral hemi-
spheres were analyzed and classifi  ed by histopathological methods or by 
  immunohistochemistry using anti  –  myelin oligodendrocyte glycoprotein 
(MOG) antibody to identify areas of infl  ammation and demyelination (  46, 47  ). 
Immunohistochemical staining for T and B cells, macrophages, and MHC 
class II molecule expression was performed as described previously (  46, 47  ) 
to evaluate the degree of lesion infl  ammatory activity. Postmortem CSF 
samples were also available from some of the MS cases (  n   = 16) obtained 
from the UK MS Tissue Bank and were used for OCB determination and 
viral DNA analysis. The set of CSF samples used in this study was rather 
  homogeneous (mean albumin concentration, 31.7 mg/dL, with a standard 
error of 2.1 and a 95% CI of 4.9; mean postmortem delay of CSF collection, 
17.1 h, with a standard error of 1.2 and a 95% CI of 2.6). 
  EBER  —  in situ hybridization.     In situ hybridization experiments were 
performed using the Epstein-Barr virus (EBER) PNA Probe/Fluorescein 
and the PNA ISH detection kit (Dako), according to the manufacturer  ’  s 
  instructions. Treatment with proteinase K was performed on frozen, PFA 
fi  xed-frozen, and paraffi   n-embedded sections at the following dilutions in 
TBS: 1:500 for 10 min, 1:100 and 1:10 for 20 min, respectively. An EBV-
associated B cell lymphoma (paraffi   n-embedded sections provided by the 
Pathology Department of S. Andrea Hospital, Rome) was used as positive 
control tissue for EBER signals. Sections were sealed in aqueous medium 
and viewed and photographed with an Axiophot Zeiss microscope equipped 
with an Axiocam digital camera, using the Axiovision 4 AC software. Dou-
ble staining for EBER and CD20 or CD138 was performed as described in 
the Supplemental Materials and methods. 
  Immunohistochemistry.     Deparaffi   nized 5-    m-thick and air-dried, acetone-
fi  xed 10-    m-thick cryosections were rehydrated with PBS and immuno-
stained with antibodies specifi  c for human CD3, CD8, CD20, MHC class II, 
MOG, CD68, CD138, Ki67, IFN-    , blood dendritic cell antigen 2, AID, 
bcl2, or activated caspase-3, and for the EBV proteins, EBNA2, LMP1, 
BFRF1, gp350/220, and p160 (Table S2, available at http://www.jem.org/
cgi/content/full/jem.20071030/DC1). For single staining, postfi  xed  sections 
were subjected to the antigen retrieval procedure and incubated for 20 min 
with 0.1% H  2  O  2   in PBS to eliminate endogenous peroxidase activity for 1 h 
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